3P Biopharmaceuticals
3P Biopharmaceuticals is a privately held Spanish CDMO, founded in 2006 and headquartered in Noáin, Spain, specializing in the development and manufacture of biologics and cell therapy products for pharmaceutical and biotech sponsors.
- Company typePrivate
- Founded2006
- HeadquartersNoáin, Spain
- Headcount251–500
- GTM typeB2B
- OfferingServices
3P Biopharmaceuticals firmographics
Firmographics- Name
- 3P Biopharmaceuticals
- Website
- https://3pbio.com
- Company type
- Private
- Founded year
- 2006
- Headcount range
- 251–500 employees
- Short description
- 3P Biopharmaceuticals is a privately held Spanish CDMO, founded in 2006 and headquartered in Noáin, Spain, specializing in the development and manufacture of biologics and cell therapy products for pharmaceutical and biotech sponsors.
- Ownership category
- akta.pro rank
3P Biopharmaceuticals industry classification
Industry- Product category
- Biologics Contract Manufacturing (CDMO)
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)
- akta.pro secondary industries
- Cell Therapy CDMO (HLAGABAD), Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
Keywords
Where 3P Biopharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Noáin
- HQ country
- Spain
- HQ region
- Europe
Markets served
3P Biopharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
3P Biopharmaceuticals product offering
Product offeringCore offering
3P Biopharmaceuticals is a contract development and manufacturing organization (CDMO) that provides development, manufacturing, and related services for biologics and cell therapy products on behalf of pharmaceutical and biotechnology clients. The company supports biological drug substance and advanced therapy programs through specialized GMP-compliant production capabilities based in Noáin, Spain.
Differentiator
Problem solved
Functional benefit
Products and services
- Biologics Development and Manufacturing Services Contract development and GMP manufacturing services for biologics products, provided to pharmaceutical and biotechnology clients requiring outsourced capacity for biological drug substances.
- Cell Therapy Product Development and Manufacturing Development and manufacturing services for cell therapy products, offered to biopharmaceutical clients developing advanced therapy medicinal products.
Companies that use 3P Biopharmaceuticals
Customer profileIdeal customer profiles1 record
3P Biopharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
3P Biopharmaceuticals competitors and assessment
Company assessmentDirect peers
- Lonza: The largest global biologics CDMO, offering mammalian and microbial biologics manufacturing plus cell-and-gene therapy services. Comparable to 3P as a biologics and cell-therapy CDMO serving biotech clients with GMP production.
- Samsung Biologics: Large-scale biologics CDMO offering mammalian cell culture, fill-finish, and aseptic manufacturing. Direct peer in mammalian biologics contract manufacturing for biopharma clients worldwide.
- Catalent: Global CDMO with strong biologics and cell-and-gene therapy manufacturing franchises. Overlaps with 3P in development, GMP production, and commercial supply of biologics and advanced therapies.
- WuXi Biologics: Global end-to-end biologics CDMO with discovery, development, and manufacturing services. Highly comparable to 3P in mammalian recombinant biologics contract manufacturing.
- Boehringer Ingelheim BioXcellence: Biologics CDMO division of Boehringer Ingelheim providing mammalian cell culture process development and GMP manufacturing. Direct competitor for biopharma clients seeking European-based biologics CDMO capacity.
- AGC Biologics: Mid-to-large global biologics CDMO offering microbial and mammalian production across multiple sites. Comparable to 3P as a multi-modality biologics contract manufacturer.
- Rentschler Biopharma: German-headquartered, family-owned biologics CDMO specializing in mammalian cell culture and complex protein manufacturing. Closely analogous mid-sized European biologics CDMO competing in the same client pool as 3P.
- Cobra Biologics (Charles River Laboratories): CDMO providing biologics and cell/gene therapy development and GMP manufacturing, now part of Charles River. Comparable to 3P in cell-therapy and biologics contract manufacturing services.
Others
- Repligen: Supplier of bioprocessing tools, single-use systems, and CDMO services used by biologics manufacturers. Comparable as an ecosystem enabler and adjacent CDMO serving the same biologics manufacturing customers as 3P.
- Polyplus (Sartorius): Provider of plasmid DNA, transfection reagents, and process services for biologics and cell/gene therapy manufacturing. Adjacent enabler to CDMOs like 3P for biologics and cell-therapy process development.
Market position
Customer concentration
3P Biopharmaceuticals social profiles
Digital presence3P Biopharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
3P Biopharmaceuticals leadership team
Management profileNumber of profiles
Profiles1 record
3P Biopharmaceuticals funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
3P Biopharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 3P Biopharmaceuticals
What does 3P Biopharmaceuticals do?
3P Biopharmaceuticals is a contract development and manufacturing organization (CDMO) that provides development, manufacturing, and related services for biologics and cell therapy products on behalf of pharmaceutical and biotechnology clients. The company supports biological drug substance and advanced therapy programs through specialized GMP-compliant production capabilities based in Noáin, Spain.
When was 3P Biopharmaceuticals founded?
3P Biopharmaceuticals was founded in 2006. It employs 251 to 500 people.
Where is 3P Biopharmaceuticals based?
3P Biopharmaceuticals is headquartered in Noáin, Spain, in the Europe region.
Who are 3P Biopharmaceuticals's main competitors?
Direct peers on record are Lonza, Samsung Biologics, Catalent, WuXi Biologics, Boehringer Ingelheim BioXcellence, AGC Biologics, Rentschler Biopharma and Cobra Biologics (Charles River Laboratories). Others are Repligen and Polyplus (Sartorius).
Does 3P Biopharmaceuticals have an API?
No public API is recorded for 3P Biopharmaceuticals.
What industry is 3P Biopharmaceuticals in?
3P Biopharmaceuticals's product category is Biologics Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO, with a secondary code of HLAGABAD, Cell Therapy CDMO. Its NAICS code is 325414 and its SIC code is 2836.